| Literature DB >> 32512819 |
Charity Mekgwa Lebepe1, Pearl Rutendo Matambanadzo1, Xolani Henry Makhoba2, Ikechukwu Achilonu3, Tawanda Zininga1,4, Addmore Shonhai1.
Abstract
Hsp70 is a conserved molecular chaperone. How Hsp70 exhibits specialized functions across species remains to be understood. Plasmodium falciparum Hsp70-1 (PfHsp70-1) and Escherichia coli DnaK are cytosol localized molecular chaperones that are important for the survival of these two organisms. In the current study, we investigated comparative structure-function features of PfHsp70-1 relative to DnaK and a chimeric protein, KPf, constituted by the ATPase domain of DnaK and the substrate binding domain (SBD) of PfHsp70-1. Recombinant forms of the three Hsp70s exhibited similar secondary and tertiary structural folds. However, compared to DnaK, both KPf and PfHsp70-1 were more stable to heat stress and exhibited higher basal ATPase activity. In addition, PfHsp70-1 preferentially bound to asparagine rich peptide substrates, as opposed to DnaK. Recombinant P. falciparum adenosylmethionine decarboxylase (PfAdoMetDC) co-expressed in E. coli with either KPf or PfHsp70-1 was produced as a fully folded product. Co-expression of PfAdoMetDC with heterologous DnaK in E. coli did not promote folding of the former. However, a combination of supplementary GroEL plus DnaK improved folding of PfAdoMetDC. These findings demonstrated that the SBD of PfHsp70-1 regulates several functional features of the protein and that this molecular chaperone is tailored to facilitate folding of plasmodial proteins.Entities:
Keywords: Hsp70; Plasmodium falciparum; chaperone function; co-expression; specificity
Mesh:
Substances:
Year: 2020 PMID: 32512819 PMCID: PMC7356358 DOI: 10.3390/biom10060856
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Comparative analysis of heat stability, nucleotide binding and hydrolysis kinetics of the Hsp70s. (a) Hsp70 far-UV spectra. The far-UV CD spectra of recombinant DnaK, KPf and PfHsp70-1 proteins were presented as molar residue ellipticity. All the three Hsp70s displayed a predominantly α-helical structure due to the negative troughs observed at 209 and 222 nm. (b) Comparative secondary structural fold of DnaK, PfHsp70-1 and KPf exposed to heat stress. The folded fraction of each protein was determined by comparing the spectral readings obtained at any given temperature with readings taken at 19 °C. (c) ATP dramatically modulates the conformation of KPf. Fluorescence emission spectra were monitored at 320–450 nm after an initial excitation at 295 nm. The tryptophan fluorescence emission spectra maxima were recorded for DnaK, PfHsp70-1 and KPf proteins in the absence or presence of 5 mM ATP/ADP. The fluorescence maxima for each protein was blue shifted in the presence of either ATP or ADP. (d) ATPase activities of PfHsp70, KPf and DnaK. Inorganic phosphate released by ATP in the presence of each Hsp70 was monitored by direct calorimetry at 595 nm wavelength. The observed basal and PfHsp40-stimulated ATPase activities of respective protein were illustrated as bar graphs. The independent activity of PfHsp40 was used as a non-ATPase control. The statistical significance of the relative ATPase activities of the proteins are shown; *p < 0.05 and **p < 0.01 as determined by ANOVA. (e) Equilibrium ATP binding kinetics of all three Hsp70s. The reported ATP binding constant for the respective Hsp70 was determined at equilibrium. Standard deviations shown represent three independent assays made using separate protein purification batches.
Kinetics for self-association of DnaK, KPf and PfHsp70-1.
| Ligand | Analyte |
| |||
|---|---|---|---|---|---|
| DnaK | DnaK + ATP | 1.38 (±0.08) × 102 | 3.83 (±0.33) × 10−4 | 4.13 (±0.30) × 10−6* | 5.15 |
| DnaK | 1.27 (±0.07) × 103 | 6.51 (±0.01) × 10−2 | 4.67 (±0.27) × 10−5 | 4.21 | |
| DnaK + ADP | 1.22 (±0.13) × 102 | 6.49 (±0.09) × 10−3 | 4.60 (±0.09) × 10−5 | 5.41 | |
| KPf | KPf + ATP | 1.54 (±0.04) × 102 | 5.44 (±0.04) × 10−3 | 3.23 (±0.03) × 10−7* | 2.30 |
| KPf | 1.32 (±0.02) × 102 | 4.17 (±0.17) × 10−5 | 5.38 (±0.08) × 10−6 | 3.17 | |
| KPf + ADP | 1.42 (±0.02) × 102 | 5.23 (±0.03) × 10−3 | 4.65 (±1.5) × 10−5 | 2.37 | |
| PfHsp70-1 | PfHsp70-1 + ATP | 2.14 (±0.04) × 104 | 1.13 (±1.2) × 10−2 | 5.28 (±0.08) × 10−7* | 4.42 |
| PfHsp70-1 | 8.51 (±1.20) × 103 | 2.04 (±0.11) × 10−3 | 2.39 (±0.09) × 10−6 | 1.20 | |
| PfHsp70-1 + ADP | 1.00 (±0.17) × 102 | 1.71 (±0.07) × 10−4 | 1.71 (±0.10) × 10−6 | 4.45 |
The table shows the binding kinetics parameters of self-association of the three Hsp70s. The ligand fraction of each protein was the immobilized protein on the GLC chip surface, and the analyte fraction was injected at a flow rate of 50 μL/min. Self-association of the three proteins was investigated either in the absence or presence of ATP/ADP. Significant variation in KD values of data obtained in the presence of ATP was based on one-way ANOVA test (*p < 0.05).
Kinetics for the interaction of DnaK/KPf/PfHsp70-1 with PfHsp40.
| Ligand | Analyte |
| |||
|---|---|---|---|---|---|
| PfHsp70-1 | PfHsp40 +ATP | 1.81 (±0.01) × 102 | 1.32 (±0.02) × 10−4 | 2.08 (±0.80) × 10−7 ** | 2.12 |
| PfHsp40 +ADP | 1.53 (±0.03) × 103 | 8.66 (±0.06) × 10−6 | 9.98 (±0.18) × 10−6 | 3.08 | |
| PfHsp40 | 1.33 (±0.03) × 103 | 9.81(±0.10) × 10−6 | 1.88 (±0.08) × 10−5 | 7.80 | |
| KPf | PfHsp40 + ATP | 1.72 (±0.02) × 102 | 7.44 (±0.04) × 10−3 | 7.23 (±0.30) × 10−7** | 1.75 |
| PfHsp40 + ADP | 1.36 (±0.26) × 102 | 5.43 (±0.03) × 10−4 | 2.62 (±0.02) × 10−6 | 2.15 | |
| PfHsp40 | 1.24 (±0.04) × 104 | 6.54 (±0.04) × 10−5 | 2.53 (±0.03) × 10−5 | 2.13 | |
| DnaK | PfHsp40 + ATP | 1.22 (±0.02) × 102 | 7.44 (±0.04) × 10−4 | 7.23 (±0.03) × 10−6* | 1.66 |
| PfHsp40 + ADP | 1.16 (±0.06) × 102 | 5.43 (±0.32) × 10−3 | 2.62 (±0.02) × 10−5 | 1.57 | |
| PfHsp40 | 1.12 (±0.02) × 102 | 7.44 (±0.04) × 10−3 | 7.23 (±0.03) × 10−5 | 2.07 |
The data were analyzed through global fitting of the sensorgrams obtained. The standard deviations about the means were obtained after three repeat experimental runs. Statistical significance of the data obtained in the presence of ATP was established by one-way ANOVA test (*p < 0.05) and (**p < 0.01).
Figure 2PfHsp70 preferentially bound to asparagine-enriched peptides. The relative affinities of DnaK, KPf and PfHsp70-1 for the various peptides were determined in the presence of 5 mM ADP. Relative affinities for peptides (A) NRLLTG versus NRNNTG; (B) ALLLMYRR versus ANNNMYRR; (C) GFRVVLMYRF versus GFRNNNMYRF are depicted as bar graphs. The error bars shown were generated from three assays conducted using independent Hsp70 protein preparations. Statistical significance was determined by one-way ANOVA (*p < 0.05 and **p < 0.01).
Figure 3PfAdoMetDC co-produced with PfHsp70-1 and KPf is structurally unique secondary structure from that co-produced with DnaK. Amino acid compositions of AdoMetDC of H. sapiens, E. coli and P. falciparum origins (a). PfAdoMetDC was co-produced either alone (NC) or in the presence of supplementary chaperone sets: DnaK + DnaJ (J + K); DnaK + DnaJ + GroEL (J + K + EL); PfHsp70-1+DnaJ (J + Pf); PfHsp70 + DnaJ + GroEL (J + Pf + EL); KPf + DnaJ (J + KPf); and KPf + DnaJ + GroEL (J + KPf + EL), respectively. The protein was then subjected to SEC-FPLC analysis (b); and far-UV CD spectrometric assays (c–f). CD spectrometric analysis was conducted either in the absence of substrate or in the presence of SAM (‘S’), the PfAdoMetDC substrate. The CD spectrum of PfAdoMetDC was presented as molar residue ellipticity (MRE; θ).
Figure 4Co-production of PfAdoMetDC with PfHsp70-1 and KPf facilitates the folding process. PfAdoMetDC co-expressed with the various chaperone sets was subjected to either ANS extrinsic fluorescence analysis (a–d) or intrinsic fluorescence analysis (e–g). PfAdoMetDC produced in the absence of supplementary chaperones (NC) or presence of various heterologous chaperones combinations: DnaK + DnaJ (J + K); DnaK + DnaJ + GroEL (J + K + EL); PfHsp70 + DnaJ (J + Pf); PfHsp70 + DnaJ + GroEL (J + Pf + EL); KPf + DnaJ (J + KPf); KPf + DnaJ + GroEL (J + KPf + EL). The fluorescence analysis was conducted in the absence or presence of the SAM (S), the PfAdometDC substrate.